Application Construction and Effect Evaluation of Family-empowered Pulmonary Rehabilitation in School-age Children With Asthma
1 other identifier
interventional
92
0 countries
N/A
Brief Summary
Study Purpose: To develop a pulmonary rehabilitation intervention program suitable for school-age children with asthma, and to evaluate its effectiveness in improving asthma control in children through a prospective randomized controlled trial. Study Methods: This is a single-center, prospective, randomized, open-label, parallel-controlled trial. Eligible subjects who meet all inclusion criteria and none of the exclusion criteria, together with their families, will be randomly assigned in a 1:1 ratio to either the intervention group (family-empowered pulmonary rehabilitation intervention) or the control group (conventional pulmonary rehabilitation care) after signing the informed consent form. Both groups will receive a 12-week core intervention period, with follow-up assessments conducted at baseline, end of intervention (12 weeks), and at 24 and 48 weeks after intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2026
CompletedFirst Posted
Study publicly available on registry
April 30, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
April 30, 2026
February 1, 2026
1.5 years
February 27, 2026
April 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Asthma control level
Evaluate using the change in the Childhood Asthma Control Test (C-ACT) score. The C-ACT score ranges from 0 to 27, with higher scores indicating better control.
Baseline
Secondary Outcomes (1)
Pulmonary function
Baseline
Study Arms (2)
Family-empowered pulmonary rehabilitation intervention group
EXPERIMENTALConventional pulmonary rehabilitation care group
OTHERInterventions
Family-empowered pulmonary rehabilitation intervention, including education, skills training, and home-based rehabilitation guidance.
Routine pulmonary rehabilitation care and regular follow-up as per clinical practice.
Eligibility Criteria
You may qualify if:
- School-aged children aged 6 to 12 years.
- Meet the diagnostic criteria for asthma according to the Guidelines for the Diagnosis and Prevention of Bronchial Asthma in Children (2025 Edition).
- Received regular inhaled asthma medications for at least 3 months, with moderate or better medication adherence (score ≥6 on the Morisky Medication Adherence Scale).
- Pulmonary function test shows obstructive ventilatory dysfunction or small airway dysfunction.
- The primary caregiver has good communication and literacy skills, can use smartphone applications (e.g., WeChat) proficiently, and is willing to participate in the study.
- Written informed consent has been obtained from the participant and their legal guardian.
You may not qualify if:
- Children in acute asthma exacerbation.
- Presence of other severe chronic diseases (e.g., congenital heart disease, neuromuscular disease, immunodeficiency disease, etc.).
- Children with mental or psychological disorders who cannot cooperate.
- Other conditions judged by the investigator to be unsuitable for participation in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2026
First Posted
April 30, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
October 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
April 30, 2026
Record last verified: 2026-02